GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 17 filers reported holding GAIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,414 | -51.7% | 2,870 | -34.0% | 0.00% | -100.0% |
| Q2 2023 | $19,475 | +58915.2% | 4,347 | -36.5% | 0.00% | 0.0% |
| Q1 2023 | $33 | +43.5% | 6,844 | -4.3% | 0.00% | 0.0% |
| Q4 2022 | $23 | -99.9% | 7,152 | +35.9% | 0.00% | – |
| Q3 2022 | $17,000 | +466.7% | 5,261 | +634.8% | 0.00% | – |
| Q2 2022 | $3,000 | +50.0% | 716 | +20.7% | 0.00% | – |
| Q1 2022 | $2,000 | -71.4% | 593 | -49.3% | 0.00% | – |
| Q4 2021 | $7,000 | +75.0% | 1,170 | +110.8% | 0.00% | – |
| Q3 2021 | $4,000 | – | 555 | +670.8% | 0.00% | – |
| Q2 2021 | $0 | – | 72 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 151,132 | $807,000 | 1.04% |
| CM Management, LLC | 90,000 | $489,000 | 0.37% |
| Greenlight Capital | 546,560 | $2,968,000 | 0.17% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $315,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $267,000 | 0.01% |
| Veritable, L.P. | 25,064 | $136,000 | 0.00% |
| Banque Cantonale Vaudoise | 3,000 | $16,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 20,056 | $107,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 15,754 | $84,000 | 0.00% |
| MORGAN STANLEY | 800 | $4,000 | 0.00% |